‘Main focus should be on developing a mass-based health insurance system’
Five years ago, in the same publication, I wrote about what are healthcare matters and what should be the priorities of the then…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘Set up fast track courts to address IPR disputes’
The Organisation of Pharmaceutical Producers in India (OPPI), much like the rest of industry has high expectations of the new…
‘New government should get its regulatory role restored’
Over the last three years medical research in India has been brought to standstill. Clinical trials are essential for affordable…
Glenmark opens antibody manufacturing facility in Switzerland
The manufacturing facility supplements the research and development capabilities and will facilitate production of clinical grade…
Indian consumers lack awareness on medical devices: AdvaMed
60 per cent of respondents think that medical devices are the same as pharmaceuticals
Focus on cross-border deals
Regional expansion to increase presence in the global markets drives M&A activity in the month of May 2014
Evolva joins forces with Malaysian University
To establish a scientific Centre of Excellence for natural products that will initially focus on the production of agarwood…
US FDA approves first generic versions of celecoxib
Celecoxib is a non-Steroidal anti-inflammatory drug
BMS and Syngene International in collaboration
Extends five-year extension of their drug discovery and development collaboration
UL EduNeering, IDMA to hold one day seminar in Mumbai in September
We see ourselves as agents of change through training, explains Kavita Mehrotra, Head, Global Strategic Alliances, UL and give…